Aleris, a leading provider of specialist healthcare in Scandinavia, has published its annual report for 2024. The report highlights a year of significant growth, operational excellence, reinforcing Aleris’ position as a frontrunner in accessible, high-quality medical care across Sweden, Norway, and Denmark.
In 2024, Aleris recorded 3.5 million patient visits, representing a 67% increase compared to 2023, driven by expanded access, high medical quality, and a growing demand for timely care.
“We are happy and proud that we serve an increasing number of patients in Scandinavia,” says Sofia Palmquist, Group CEO of Aleris. “High accessibility, excellent service and high quality throughout the patient journey improves health for the people in Scandinavia”.
Aleris achieved growth across all business segments:
The company also expanded its footprint with the opening of new facilities in Odense (Denmark), Tromsø and Bodø (Norway), and a new eye clinic in Halmstad (Sweden). These strategic investments reflect Aleris’ ambition to grow in Scandinavia and improve access to care and reinforce its market position in specialist fields such as orthopaedics, mental health, and medical diagnostics.
“Specialization and high volume are at the heart of our success,” says Palmquist. “By focusing on what we do best, we can provide high-quality healthcare while helping more people and contributing to a more efficient healthcare system”.
Aleris continued to invest in digital healthcare, such as remote consultations and AI-enhanced diagnostics, reducing administrative burden and improving care delivery. A strengthened focus on leadership, learning and cross-border knowledge sharing ensured consistent medical quality and elevated the company’s attractiveness as an employer.
“We believe in the power of our employees’ engagement and leadership abilities to drive development,” Palmquist adds. “Our teams continue to shape the future of healthcare—together, we make a difference for people throughout Scandinavia”.
The 2024 report also details Aleris’ work within sustainability, innovation, and operational efficiency, underscoring the company’s long-term commitment to delivering value for patients, public partners, and society at large.